
1. plos one. 2014 apr 7;9(4):e93782. doi: 10.1371/journal.pone.0093782. ecollection 
2014.

duffy antigen receptor chemokine (darc) polymorphisms involvement 
acquisition inhibitory anti-duffy binding protein ii (dbpii) immunity.

souza-silva fa(1), torres lm(1), santos-alves jr(1), tang ml(1), sanchez ba(2),
sousa tn(1), fontes cj(3), nogueira pa(4), rocha rs(1), brito cf(1), adams jh(5),
kano fs(1), carvalho lh(1).

author information: 
(1)laboratório de malária, centro de pesquisas rené rachou, fundação oswaldo cruz
(fiocruz), belo horizonte, mg, brasil.
(2)universidade federal de mato grosso, campus sinop, sinop, mt, brasil.
(3)julio müller university hospital, universidade federal de mato grosso, cuiabá,
mt, brasil.
(4)centro de pesquisas leônidas & maria deane, fiocruz amazônia, manaus, am,
brasil.
(5)department global health, college public health, university south
florida, tampa, florida, united states america.

the plasmodium vivax duffy binding protein (pvdbp) erythrocytic receptor,
the duffy antigen receptor chemokines (darc), involved major p.
vivax erythrocyte invasion pathway. open cohort study analyze darc
genotypes relationship pvdbp immune responses carried 620
volunteers agricultural settlement brazilian amazon. three
cross-sectional surveys conducted 6-month intervals, comprising 395, 410,
and 407 subjects, respectively. incidence rates p. vivax infection was
2.32 malaria episodes per 100 person-months survey (95% confidence interval
[ci] 1.92-2.80/100 person-month) and, p. falciparum, 0.04 per 100
person-months (95% ci 0.007-0.14/100 person-month). distribution darc
genotypes consistent heterogeneous ethnic origins amazon
population, predominance non-silent darc alleles: fy*a > fy*b. the
12-month follow-up study demonstrated association darc genotypes and
total igg antibodies measured elisa targeting pvdbp (region ii, dbpii or
regions ii-iv, dbpii-iv). naturally acquired dbpii specific binding
inhibitory antibodies (biabs) tended frequent heterozygous
individuals carrying darc-silent allele (fy*bes). results provide
evidence darc polymorphisms may influence naturally acquired inhibitory 
anti-duffy binding protein ii immunity.

doi: 10.1371/journal.pone.0093782 
pmcid: pmc3977910
pmid: 24710306  [indexed medline]

